首页 | 本学科首页   官方微博 | 高级检索  
     

甲亢手术与丙基硫氧嘧啶对131I疗效的影响
引用本文:石根明,徐勤,杨以理,叶安方,朱诚忆. 甲亢手术与丙基硫氧嘧啶对131I疗效的影响[J]. 中华放射医学与防护杂志, 2006, 26(1): 68-70
作者姓名:石根明  徐勤  杨以理  叶安方  朱诚忆
作者单位:310003,杭州,浙江大学医学院附属第一医院化疗科
基金项目:浙江省教育厅基金资助项目(20030237)
摘    要:目的 探讨甲亢术后复发和丙基硫氧嘧啶(PTU)治疗后对^131I疗效的影响。方法 2003年1月至2004年12月在我院核医学科治疗的甲亢术后复发病人,未经过抗甲状腺药物治疗41例为术后复发组;按同时期^131I治疗次序编号,从未经过手术及抗甲状腺药物治疗的病例中随机抽取41例为对照组(未治疗组);从只经PTU治疗的病例中随机抽取41例为PTU组,采用标准剂量法给予^131I治疗,分析治疗后3与6个月随访资料。结果 未治疗组^131I治疗后3和6个月甲亢治愈率分别为90.24%(37141)和92.68%(38/41),无效率分别为9.76%(4/41)和7.32%(3/41);PTU治疗组^131I治疗后3和6个月甲亢治愈率分别为43.90%(18/41)和53.66%(22/41),无效率分别为56.10%(23/41)和46.34%(19/41),与未治疗组比较均为P〈0.01;术后复发组^131I治疗后3和6个月甲亢治愈率分别为68.29%(28/41)和70.73%(29/41),无效率分别为31.71%(13/41)和29.27%(12/41),与未治疗组比较均为P〈0.05。结论 甲亢在^131I治疗前经外科手术或PTU治疗,将影响^131I治疗效果,降低甲亢^131I的治愈率。

关 键 词:甲状腺功能亢进 丙基硫氧嘧啶 外科治疗 ^131I
收稿时间:2005-08-08
修稿时间:2005-08-08

Iufluence of surgical or propylthiouracil pretreatment on the efficacy of iodine-131 therapy in hyperthyroidism
SHI Gen-ming,XU Qin,YANG Yi-li. Iufluence of surgical or propylthiouracil pretreatment on the efficacy of iodine-131 therapy in hyperthyroidism[J]. Chinese Journal of Radiological Medicine and Protection, 2006, 26(1): 68-70
Authors:SHI Gen-ming  XU Qin  YANG Yi-li
Affiliation:The First Affiliated Hospital, College of Medical Sciences, Zhejiang University, Hangzhou 310003, China
Abstract:Objective To investigate the influence of surgical or propylthiouracil(PTU) pretreatment on the efficacy of radioactive iodine therapy in hyperthyroidism. Methods A group(group 1) of 41 hyperthyroidism patients relapsed after surgery were treated with ~(131)I in our department from 2003 through 2004. During that period,another group(group 2) of 41 cases were selected randomly from patients untreated either surgically or chemically before oral administration of ~(131)I,and a third group(group 3) of 41 cases were selected randomly from those pretreated only with PTU.We analysed the results of these three groups of patients after followed_up for 3 and 6 months separately after ~(131)I therapy. Results Approximately 90.24%(37/41 cases) and 92.68%(38/41 cases) of patients in group 2 without any pretreatment were cured 3 months and 6 months after ~(131)I treatment,respectively,and 9.76%(4/41 cases) and 7.32%(3/41 cases) of them did not respond to ~(131)I treatment.About 43.90%(18/41 cases) and 53.66%(22/41 cases) of patients pretreated with PTU(group 3)were cured at 3 and 6 months,respectively,and approximately 56.10%(23/41 cases) and 46.34%(19/41 cases) of this group patients did not respond to ~(131)I treatment at 3 and 6 months,respectively(P<0.01) compared with the un_pretreated group.About 68.29%(28/41 cases) and 70.73%(29/41 cases) of relapsed patients after surgery(group 1) were cured at 3 and 6 months after ~(131)I treatment,respectively,and 31.71%(13/41) and 29.27%(12/41) of them did not respond to ~(131)I treatment(P<0.05) as compared with the unpretreated group. Conclusion (Surgery or PTU) pretreatment of hyperthyroidism patient before ~(131)I treatment can affect the efficacy of ~(131)I therapy,resulting in reduction of the cure rate.
Keywords:Hyperthyroidism   Propylthiouracil   Surgical treatment   Iodine-131
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中华放射医学与防护杂志》浏览原始摘要信息
点击此处可从《中华放射医学与防护杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号